HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).

AbstractBACKGROUND:
Thymic neuroendocrine tumors (Th-NET) present a poor prognosis for patients with multiple endocrine neoplasia type 1 (MEN1). The purpose of this article was to study the clinical, biological, and pathological features of Th-NET in a large cohort of patients with MEN1.
METHODS:
The 761-patient MEN1 cohort from the GTE registry was used (Groupe des Tumeurs Endocrines).
RESULTS:
The actuarial probability of occurrence was 2.6% (range, 1.3-5.5%) at aged 40 years. All, except one, Th-NET patients were men. Four patients had no other associated lesions. The youngest patient was aged 16 years. Mean age at the time of diagnosis was 42.7 (range, 16.1-67.5) years. The 10-year probability of survival was 36.1% (range, 11.5-62%). Seven patients (33%) belonged to clustered MEN1 families. The spectrum of associated lesions in patients with Th-NET was not statistically different from the spectrum of the remainder of the cohort. Various endocrine markers were high, but none were sensitive or specific enough to be useful for Th-NET detection. CT-scan and MRI were always positive at the time of diagnosis. No particular mutation was found to be associated with Th-NET. Five cases underwent prophylactic thymectomy without success.
CONCLUSIONS:
Several end points may be helpful for future guidelines: (1) earlier detection of Th-NET in MEN1 patients is required; (2) screening of both sexes is necessary; (3) a prospective study comparing MRI vs. CT scan in yearly screening for Th-NET is needed; (4) a reinforced screening program must be established for patients who belong to clustered families; and (5) thymectomies must be performed in specialized centers.
AuthorsPierre Goudet, Arnaud Murat, Catherine Cardot-Bauters, Philippe Emy, Eric Baudin, Hélène du Boullay Choplin, Yves Chapuis, Jean-Louis Kraimps, Jean-Louis Sadoul, Antoine Tabarin, Bruno Vergès, Bruno Carnaille, Patricia Niccoli-Sire, Annie Costa, Alain Calender, GTE network (Groupe des Tumeurs Endocrines)
JournalWorld journal of surgery (World J Surg) Vol. 33 Issue 6 Pg. 1197-207 (Jun 2009) ISSN: 1432-2323 [Electronic] United States
PMID19294466 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
Topics
  • Adolescent
  • Adult
  • Aged
  • Biomarkers, Tumor (blood)
  • Cohort Studies
  • Female
  • Guidelines as Topic
  • Humans
  • Male
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 1 (blood, epidemiology, genetics, pathology)
  • Registries
  • Sex Factors
  • Thymus Neoplasms (blood, epidemiology, genetics, pathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: